Zosynin Galaxy Containers (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Zosyn drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
NON-PROPRIETARY NAME: | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
SUBSTANCE NAME: | TAZOBACTAM SODIUM; PIPERACILLIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1998-03-01 |
END MARKETING DATE: | 0000-00-00 |
Zosyn in Galaxy Containers HUMAN PRESCRIPTION DRUG Details:
Item Description | Zosyn in Galaxy Containers from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250; 2(mg/50mL; g/50mL) |
START MARKETING DATE: | 1998-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0206-2409_2d19ba82-6c84-4e70-ba69-09e5bc31c2bf |
PRODUCT NDC: | 0206-2409 |
APPLICATION NUMBER: | NDA050750 |
Other TAZOBACTAM SODIUM; PIPERACILLIN SODIUM Pharmaceutical Manufacturers / Labelers: